- Exchange: EN Paris
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Ipsen SA (IPN)
| Open: | 27.1200 | Day's Range: | 27.1200 - 27.2800 | Volume: | 13,129 |
|---|---|---|---|---|---|
| Previous Close: | 27.0650 | 52wk Range: | 17.5000 - 28.3450 | 1-Yr Rtn: | +39.23% |
Key Statistics for IPN
| Current P/E Ratio (ttm) | 24.0708 |
|---|---|
| Estimated P/E(12/2013) | 14.6001 |
| Relative P/E vs. CAC | 1.8135 |
| Earnings Per Share (EUR) (ttm) | 1.1300 |
| Est. EPS (EUR) (12/2013) | 1.8630 |
| Est. PEG Ratio | 1.5083 |
| Market Cap (M EUR) | 2,287.78 |
| Shares Outstanding (M) | 84.11 |
| 30 Day Average Volume | 36,082 |
| Price/Book (mrq) | 1.3832 |
| Price/Sale (ttm) | 1.8551 |
| Dividend Indicated Gross Yield | 2.94% |
| Cash Dividend (EUR) | 0.8000 |
| Last Dividend | 06/05/2013 |
| 5 Year Dividend Growth | 5.92% |
| Next Earnings Announcement | 08/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for IPN
Company Profile & Key Executives for IPN
Ipsen SA manufactures and markets a wide range of medical drugs for targeted disease areas including oncology, endocrinology, and neuromuscular disorders.
| Marc De GaridelChairman/CEO | Christel BoriesDeputy CEO |
| Susheel SurpalExec VP/CFO | Nathalie JoannesExec VP/General Counsel |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
IPN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page